【Point Biopharma盘前涨超80% 报道称将被礼来收购】礼来以每股12.50美元现金收购Point Biopharma，交易总额约为14亿美元，交易预计将在2023年底前完成。Point Biopharma盘前涨超80%。 ...

[Point Biopharma jumped more than 80% premarket on report of acquisition by Eli Lilly] Eli Lilly is buying Point Biopharma for $12.50 per share in cash, in a deal valued at about $1.4 billion, and the ...